Apr 29, 2019 · To investigate the roles of gastrin-releasing peptide (ProGRP) in the diagnosis of small cell lung cancer (SCLC). We retrospectively analyzed data from 11,206 patients with clinical …

Pro-gastrin-releasing-peptide, also known as Pro-GRP, is a gastrin-releasing peptide (GRP) precursor, a neurotransmitter that belongs to the bombesin -related neuromedin B family. GRP stimulates the …

Sep 1, 2025 · Progastrin-releasing peptide (ProGRP) is a more sensitive and specific biomarker of SCLC than neuron-specific enolase (NSE). We investigated whether ProGRP was associated with …

Aim: To investigate the diagnostic and prognostic significance of pro-gastrin-releasing peptide (ProGRP) in non-small cell (NSCLC) and small cell lung cancer (SCLC) and compare this marker with other …

Apr 4, 2024 · Pro-gastrin-releasing peptide (ProGRP) is a glycoprotein that serves as a valuable tumor marker, primarily known for its role in the diagnosis and monitoring of Small Cell Lung Cancer (SCLC).

Jun 23, 2022 · ProGRP is a promising biochemical marker of small cell lung cancer, especially sensitive in patients with distant metastases (in the brain, liver, and bones).

Because of its high sensitivity and specificity, plasma ProGRP could be the marker of choice for the diagnosis and chemotherapy monitoring of patients with SCLC.

Jul 23, 2024 · Recently, ProGRP has emerged as a circulating biomarker for small cell lung cancer (SCLC), a subtype of aggressive and poorly differentiated neuroendocrine neoplasm (NEN).

Sep 28, 2016 · Background: Progastrin-releasing peptide (proGRP) is a recently identified biomarker of small cell lung cancer (SCLC). We evaluated the usefulness of plasma proGRP level as a tumor …

Aug 1, 2021 · Progastrin-releasing peptide (ProGRP) is a recently identified biomarker for small-cell lung cancer (SCLC), a Gastrin-Releasing-Peptide precursor. For supporting diagnosis of SCLC, ProGRP …